Table 1.
The baseline characteristics of CRC patients in the multiple datasets.
| Clinical Characteristics | TCGA cohort | GSE39582 | ICGC cohort | GSE14333 |
|---|---|---|---|---|
| n=435 | n=533 | n=414 | n=184 | |
| Age (median, range) | 66.89 (31-90) | 66.89 (22-97) | 66.61 (31-90) | 65.75 (26-92) |
| Gender (%) | ||||
| Female | 204 (46.9%) | 245 (46.0%) | 198 (47.8%) | 86 (46.7%) |
| Male | 229 (52.6) | 288 (54.0%) | 216 (52.2%) | 98 (53.3%) |
| Unknown | 2 (0.5%) | 0 (0%) | 0 (0%) | 0 (0%) |
| M(%) | ||||
| M0 | 321 (73.8%) | 463 (86.9%) | NA | NA |
| M1 | 57 (13.1%) | 50 (9.4%) | NA | NA |
| Mx | 49 (11.3%) | 1 (0.2%) | NA | NA |
| Unknown | 8 (1.8%) | 19 (3.5%) | NA | NA |
| N(%) | ||||
| N0 | 254 (58.4%) | 291 (54.6%) | NA | NA |
| N1 | 99 (22.8%) | 128 (24.0%) | NA | NA |
| N2 | 80 (18.3%) | 86 (16.1%) | NA | NA |
| N3 | 0 (0%) | 5 (0.9%) | NA | NA |
| Unknown | 2 (0.5%) | 23 (4.3%) | NA | NA |
| Stage (%) | ||||
| Stage I | 73 (16.8%) | 31 (5.8%) | NA | 32 (17.4%) |
| Stage II | 168 (38.6%) | 257 (48.2%) | NA | 78 (42.4%) |
| Stage III | 124 (28.5%) | 192 (36.0%) | NA | 74 (40.2%) |
| Stage IV | 57 (13.1%) | 49 (9.2%) | NA | 0 (0%) |
| Unknown | 13 (3.0%) | 4 (0.8%) | NA | 0 (0%) |
| Status | ||||
| Alive | 345 (79.3%) | 370 (69.4%) | 375 (90.6%) | 150 (81.5%) |
| Dead | 88 (20.2%) | 163 (30.6%) | 39 (9.4%) | 34 (17.4%) |
| Unknown | 2 (0.5%) | 0 (0%) | 0 (0%) | 0 (0%) |
NA, not available.